BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26619995)

  • 1. Post-treatment weight change in oral cavity and oropharyngeal squamous cell carcinoma.
    Zhang Z; Brown JC; O'Malley BW; Troxel AB; Bauml JM; Rubnitz KR; Grosso CM; Weinstein GS; Schmitz KH
    Support Care Cancer; 2016 May; 24(5):2333-2340. PubMed ID: 26619995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of psychosocial factors over time among HPV+ oropharyngeal cancer and tobacco-related oral cavity cancer patients.
    Janz TA; Momin SR; Sterba KR; Kato MG; Armeson KE; Day TA
    Am J Otolaryngol; 2019; 40(1):40-45. PubMed ID: 30322742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Koole K; Clausen MJ; van Es RJ; van Kempen PM; Melchers LJ; Koole R; Langendijk JA; van Diest PJ; Roodenburg JL; Schuuring E; Willems SM
    Mol Diagn Ther; 2016 Aug; 20(4):363-74. PubMed ID: 27278367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological trends of oropharyngeal and oral cavity squamous cell carcinomas in Northern New England, 2000-2013.
    Owosho AA; Velez M; Tyburski A; Hofheins J; Wiley R; Stansbury T; Gbadamosi SO; Ryder JS
    Cancer Causes Control; 2019 Mar; 30(3):291-299. PubMed ID: 30729358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma.
    Ljøkjel B; Haave H; Lybak S; Aarstad HH; Karlsdottir A; Vintermyr OK; Aarstad HJ
    Acta Otolaryngol; 2014 Sep; 134(9):964-73. PubMed ID: 24963968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Radiation Therapy Refusal in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Prasad A; Carey RM; Brody RM; Bur AM; Cannady SB; Ojerholm E; Newman JG; Ibrahim S; Brant JA; Rajasekaran K
    Laryngoscope; 2022 Feb; 132(2):339-348. PubMed ID: 34254672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.
    Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
    Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of head and neck squamous cell carcinoma in The Netherlands during the era of HPV-related oropharyngeal squamous cell carcinoma. Is there really evidence for a change?
    van Monsjou HS; Schaapveld M; van den Brekel MW; Balm AJ
    Oral Oncol; 2015 Oct; 51(10):901-7. PubMed ID: 26216340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee DS; Mahal RS; Tharakan T; Cathryn Collopy ; Kallogjeri D; Thorstad WL; Adkins DR; Oppelt P; Ley J; Wick CC; Zevallos J
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1089-1096. PubMed ID: 36939390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
    Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
    BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specimen oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma.
    Horwich P; MacKay C; Bullock M; Taylor SM; Hart R; Trites J; Geldenhuys L; Williams B; Rigby MH
    J Otolaryngol Head Neck Surg; 2021 Jun; 50(1):37. PubMed ID: 34154663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.